Study on Inhibitory Effect of MaiMenDong Decoction and WeiJing Decoction Combination with Cisplatin on NCI-A549 Xenograft in Nude Mice and Its Mechanism
Year: 2017
Type: article
Abstract: MaiMenDong Decoction and WeiJing Decoction (Jin formula) is a traditional Chinese medication that consists of 8 medicinal plants, which recorded in the classical TCM literature Jin Kui Yao Lue and has been utilized in the treatment of lung diseases for hundreds of years in China.The present study aimed to determine the anti-tumor activity and the underlying mechanisms of Jin formula combined with cisplatin in the treatment of non-small cell lung cancer (NSCLC).Xenograft model of NCI-A549 was established in Balb/c nude mice.Five groups, including normal, MOCK, Jin, cisplatin (DDP), and Jin+DDP were included in the study.We found that Jin formula ameliorated the body weight loss caused by DDP 15 days after drug administration.Moreover, the combination of Jin with DDP enhanced the anti-tumor function of DDP.Microarray analysis showed that Jin suppressed gene expression of certain pathways which regulating cell cycle and apoptosis.Furthermore, DDP mainly decreased the gene expression level of angiogenesis associated factors, such as VEGFA, TGF-β and MMP-1.Moreover, co-treatment with Jin and DDP not only down-regulated Bcl-2 and E2F1, but also decreased the expression of MYC, MET, and MCAM.In addition, co-formula decreased the levels of p-AKT (thr308) and p-PTEN, increased Bax/Bcl-2 value, and resulted in apoptosis of tumor cells.Taken together, Jin+DDP significantly inhibited the growth of A549 cell transplanted solid tumor with slight side effect compared to the treatment by DDP only, and had a better effect than the Jin group.The mechanisms may be mainly associated with inactivation of PI3K/AKT pathway and apoptosis induction.
Source: Journal of Cancer
DOI: 10.7150/jca.17720
Authors: Fei Xiong, Miao Jiang, Meijuan Chen, Xiaoxia Wang, Shiping Zhang, Jing Zhou, Ke Li, Yan Sheng, Lian Yin, Yuping Tang, Lihong Ye, Mianhua Wu, Haian Fu, Xu Zhang
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,337
Funders: Emory University, European Commission, National Natural Science Foundation of China, Government of Jiangsu Province, Nanjing University of Chinese Medicine, Nanjing University, Priority Academic Program Development of Jiangsu Higher Education Institutions, National Institutes of Health, National Cancer Institute
OpenAlex ID: W2746342104
